Sanara MedTech COO has shares withheld for taxes

Sanara MedTech Inc. reported a routine equity compensation event for Chief Operating Officer Jacob A. Waldrop.

Rhea-AI Filing Summary

Sanara MedTech Inc. reported a routine equity compensation event for Chief Operating Officer Jacob A. Waldrop. As 1,551 shares of previously granted restricted stock vested, 378 shares of common stock were withheld by the company to satisfy tax withholding obligations. The filing states that no shares were issued or sold in this transaction. Following the tax withholding disposition, Waldrop directly holds 24,377 shares of Sanara MedTech Inc. common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 378 shares

Exercise Price or Tax Liability 1 txn

Insider Waldrop Jacob A.

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	378	$20.01	$8K

Holdings After Transaction: Common Stock — 24,377 shares (Direct)

Footnotes (1)

1. F1. Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,551 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

Key Figures

Shares withheld for taxes: 378 shares Restricted stock vested: 1,551 shares Shares held after transaction: 24,377 shares +1 more

4 metrics

Shares withheld for taxes 378 shares Withheld to satisfy tax obligations on restricted stock vesting

Restricted stock vested 1,551 shares Annual vesting of previously granted restricted stock

Shares held after transaction 24,377 shares Direct holdings of Jacob A. Waldrop following withholding

Assigned per-share value $20.01 per share Price per share on vesting date as reported on Nasdaq Capital Market

Key Terms

restricted stock, tax withholding obligations, per-share value, Nasdaq Capital Market

4 terms

restricted stock financial

"in connection with the annual vesting of 1,551 shares of restricted stock previously granted"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

tax withholding obligations financial

"withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting"

per-share value financial

"The per-share value assigned to the shares withheld reflects the price per share"

Nasdaq Capital Market financial

"price per share on the date on which the shares vested as reported on the Nasdaq Capital Market"

The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Sanara MedTech (SMTI) COO Jacob Waldrop report in this Form 4?

COO Jacob Waldrop reported a tax-related share disposition. When 1,551 restricted stock shares vested, 378 shares were withheld by Sanara MedTech to cover tax obligations. The filing clarifies no shares were issued or sold in the market.

How many Sanara MedTech (SMTI) shares were withheld for taxes in this filing?

The filing shows 378 shares of Sanara MedTech common stock were withheld for tax obligations. This occurred in connection with the vesting of 1,551 previously granted restricted stock shares, and represents a non-market, compensation-related transaction.

Were any Sanara MedTech (SMTI) shares sold by Jacob Waldrop in this Form 4?

No, the Form 4 states that no shares were issued or sold in this transaction. The 378 shares reported represent stock withheld by Sanara MedTech solely to satisfy tax withholding obligations upon restricted stock vesting.

How many Sanara MedTech (SMTI) shares does Jacob Waldrop hold after this transaction?

After the tax withholding event, Jacob Waldrop directly holds 24,377 shares of Sanara MedTech common stock. This figure reflects his position following the withholding of 378 shares for taxes tied to restricted stock vesting.

What triggered the tax withholding disposition reported for Sanara MedTech (SMTI)?

The tax withholding disposition was triggered by the annual vesting of 1,551 restricted stock shares previously granted to Jacob Waldrop. To cover related tax obligations, Sanara MedTech withheld 378 shares, without issuing or selling any shares into the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/16/2026 - 04:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Waldrop Jacob A.

(Last) (First) (Middle)

1200 SUMMIT AVE

SUITE 414

(Street)

FORT WORTH TEXAS 76102

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sanara MedTech Inc. [ SMTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/15/2026		F		378(1)	D	$20.01(1)	24,377	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,551 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

	/s/ Jacob A. Waldrop	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)